Recombinant Human KLK13 (C-6His)

Description

EnkiLife provides the Recombinant Human KLK13 (C-6His) protein,aslo know as Kallikrein-13,Kallikrein-Like Protein 4,KLK-L4,KLK13,KLKL4, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Kallikrein 13 is produced by our Mammalian expression system and the target gene encoding Gly17-Ile262 is expressed with a 6His tag at the C-terminus.Accession:Q9UKR3. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:28.03 KDa. Background:Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many Kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen Kallikrein subfamily members located in a cluster on chromosome 19. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers. Alternate splicing of this gene results in multiple transcript variants encoding the same protein.